SAR125844: Clinical Trials

3 trials of SAR125844, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow SAR125844: new trials by email Literature Review of SAR125844 trials Research Report on SAR125844

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification
SAR125844 - Neoplasm Malignant
Phase 2CompletedSanofi12015-11-012016-03-23
Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients
SAR125844 - Neoplasm Malignant
Phase 1CompletedSanofi702012-09-012016-02-17
Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors
SAR125844 - Malignant Solid Tumors
Phase 1CompletedSanofi722011-07-012016-04-13

Conditions studied

Neoplasms (2)

Sponsors

Sanofi (3)

Countries

Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  South Korea (1)  ·  Spain (1)  ·  United States (1)

Results publications

PMID 29145039

NIH funding

2014 (1)